Melasma like hyperpigmentation on face: A rare side effect of imatinib

---

Case Report

Author Details : Anusha Gupta, Sunil Kumar*, Saurav Chaturvedi, Apoorva Nirmal

Volume : 5, Issue : 2, Year : 2018

Article Page : 79-80

https://doi.org/10.18231/2348-7240.2018.0019

Suggest article by email

Get Permission

---

Abstract

Imatinib mesylate is a cytotoxic agent that is used in chronic myeloid leukaemia. Common reported side effect is hypopigmentation; here we report a 48 year old female who developed hyperpigmentation as melasma on her face while taking imatinib mesylate in a dose of 400 mg daily for chronic myeloid leukaemia.

Keywords: Drug-induced pigmentation, Imatinib-mesylate, Melasma, Chronic myeloid leukemia.

How to cite : Gupta A, Kumar S, Chaturvedi S, Nirmal A, Melasma like hyperpigmentation on face: A rare side effect of imatinib. Ann Geriatr Educ Med Sci 2018;5(2):79-80

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.